IBDEI0EF ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6578,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,6578,1,5,0)
 ;;=5^H/O Ovarian Cancer
 ;;^UTILITY(U,$J,358.3,6578,2)
 ;;=^295221
 ;;^UTILITY(U,$J,358.3,6579,0)
 ;;=V10.46^^31^412^67
 ;;^UTILITY(U,$J,358.3,6579,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6579,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,6579,1,5,0)
 ;;=5^H/O Prostate Cancer
 ;;^UTILITY(U,$J,358.3,6579,2)
 ;;=^295224
 ;;^UTILITY(U,$J,358.3,6580,0)
 ;;=V10.06^^31^412^68
 ;;^UTILITY(U,$J,358.3,6580,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6580,1,4,0)
 ;;=4^V10.06
 ;;^UTILITY(U,$J,358.3,6580,1,5,0)
 ;;=5^H/O Rectal/Anal Cancer
 ;;^UTILITY(U,$J,358.3,6580,2)
 ;;=^295208
 ;;^UTILITY(U,$J,358.3,6581,0)
 ;;=V10.52^^31^412^69
 ;;^UTILITY(U,$J,358.3,6581,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6581,1,4,0)
 ;;=4^V10.52
 ;;^UTILITY(U,$J,358.3,6581,1,5,0)
 ;;=5^H/O Renal Cancer
 ;;^UTILITY(U,$J,358.3,6581,2)
 ;;=H/o Renal Cancer^295229
 ;;^UTILITY(U,$J,358.3,6582,0)
 ;;=V10.04^^31^412^71
 ;;^UTILITY(U,$J,358.3,6582,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6582,1,4,0)
 ;;=4^V10.04
 ;;^UTILITY(U,$J,358.3,6582,1,5,0)
 ;;=5^H/O Stomach Cancer
 ;;^UTILITY(U,$J,358.3,6582,2)
 ;;=^295206
 ;;^UTILITY(U,$J,358.3,6583,0)
 ;;=V10.47^^31^412^72
 ;;^UTILITY(U,$J,358.3,6583,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6583,1,4,0)
 ;;=4^V10.47
 ;;^UTILITY(U,$J,358.3,6583,1,5,0)
 ;;=5^H/O Testicular Cancer
 ;;^UTILITY(U,$J,358.3,6583,2)
 ;;=^295225
 ;;^UTILITY(U,$J,358.3,6584,0)
 ;;=V10.83^^31^412^70
 ;;^UTILITY(U,$J,358.3,6584,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6584,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,6584,1,5,0)
 ;;=5^H/O Skin Cancer
 ;;^UTILITY(U,$J,358.3,6584,2)
 ;;=H/O Skin Cancer^295241
 ;;^UTILITY(U,$J,358.3,6585,0)
 ;;=285.22^^31^412^6
 ;;^UTILITY(U,$J,358.3,6585,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6585,1,4,0)
 ;;=4^285.22
 ;;^UTILITY(U,$J,358.3,6585,1,5,0)
 ;;=5^Anemia In Cancer
 ;;^UTILITY(U,$J,358.3,6585,2)
 ;;=^321978
 ;;^UTILITY(U,$J,358.3,6586,0)
 ;;=285.21^^31^412^7
 ;;^UTILITY(U,$J,358.3,6586,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6586,1,4,0)
 ;;=4^285.21
 ;;^UTILITY(U,$J,358.3,6586,1,5,0)
 ;;=5^Anemia In Renal Dis
 ;;^UTILITY(U,$J,358.3,6586,2)
 ;;=^321977
 ;;^UTILITY(U,$J,358.3,6587,0)
 ;;=285.29^^31^412^9
 ;;^UTILITY(U,$J,358.3,6587,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6587,1,4,0)
 ;;=4^285.29
 ;;^UTILITY(U,$J,358.3,6587,1,5,0)
 ;;=5^Anemia Of Chronic Dis
 ;;^UTILITY(U,$J,358.3,6587,2)
 ;;=^321979
 ;;^UTILITY(U,$J,358.3,6588,0)
 ;;=284.9^^31^412^10
 ;;^UTILITY(U,$J,358.3,6588,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6588,1,4,0)
 ;;=4^284.9
 ;;^UTILITY(U,$J,358.3,6588,1,5,0)
 ;;=5^Aplastic Anemia NOS
 ;;^UTILITY(U,$J,358.3,6588,2)
 ;;=^7020
 ;;^UTILITY(U,$J,358.3,6589,0)
 ;;=282.61^^31^412^75
 ;;^UTILITY(U,$J,358.3,6589,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6589,1,4,0)
 ;;=4^282.61
 ;;^UTILITY(U,$J,358.3,6589,1,5,0)
 ;;=5^Hemoglobin S Disease
 ;;^UTILITY(U,$J,358.3,6589,2)
 ;;=^267981
 ;;^UTILITY(U,$J,358.3,6590,0)
 ;;=282.7^^31^412^74
 ;;^UTILITY(U,$J,358.3,6590,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6590,1,4,0)
 ;;=4^282.7
 ;;^UTILITY(U,$J,358.3,6590,1,5,0)
 ;;=5^Hemoglobin C Disease
 ;;^UTILITY(U,$J,358.3,6590,2)
 ;;=^87629
 ;;^UTILITY(U,$J,358.3,6591,0)
 ;;=283.9^^31^412^76
 ;;^UTILITY(U,$J,358.3,6591,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6591,1,4,0)
 ;;=4^283.9
 ;;^UTILITY(U,$J,358.3,6591,1,5,0)
 ;;=5^Hemolytic Anemia,Acquired
 ;;^UTILITY(U,$J,358.3,6591,2)
 ;;=^7071
 ;;^UTILITY(U,$J,358.3,6592,0)
 ;;=283.0^^31^412^77
 ;;^UTILITY(U,$J,358.3,6592,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI0EF
